Timofibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85P20FW39R. European Medicines Agency schedules Timofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11068MIG. Timofibrate generally arises in the molecular formula C14H16CLNO4S. The term TIMOFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) TIMOFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule timofibrate under HS 29341000 and SITC 51579. As of Q4 2014, TIMOFIBRATE remains the US FDA Preferred Term for this commodity. Timofibrate bears US NLM identifiers UMLS ID C2699947 and NCI Concept Code C75260. SMILES: Clc1ccc(OC(C(=O)N2C(CSC2)C(=O)O)(C)C)cc1.